Bayswater, Australia
Established in 2019, it is Australia’s newest GMP contract analytical testing service provider for the pharmaceutical, life science, clinical trial, and veterinary industries. What sets Pharmalytics apart is its team, comprised of industry pioneers, with unparalleled experience in pharmaceutical analysis, quality assurance, and regulatory affairs, making it unlike any other lab. Additionally, as the only contract testing facility in Australia with full electronic data integrity and quality management systems, Pharmalytics ensures zero tolerance for ageing equipment, redundant processes, or human error of any kind.
Pharmalytics offers a range of services including Pharmacopoeial testing, raw material and finished product testing, method development and validation, ICH stability storage and testing, as well as research and development. Notably, the company also provides medicinal cannabis testing, including TGO93 requirements, and extractable and leachable testing design and analysis.
For investors seeking opportunities in the pharmaceutical industry, Pharmalytics presents an innovative and promising venture within Australia.
